Methyl (S)-2-(dibenzylamino)-3-(p-tolyl)propanoate

ID: ALA5182352

Chembl Id: CHEMBL5182352

PubChem CID: 168274365

Max Phase: Preclinical

Molecular Formula: C25H27NO2

Molecular Weight: 373.50

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)[C@H](Cc1ccc(C)cc1)N(Cc1ccccc1)Cc1ccccc1

Standard InChI:  InChI=1S/C25H27NO2/c1-20-13-15-21(16-14-20)17-24(25(27)28-2)26(18-22-9-5-3-6-10-22)19-23-11-7-4-8-12-23/h3-16,24H,17-19H2,1-2H3/t24-/m0/s1

Standard InChI Key:  HNMAHTYIVGTSJW-DEOSSOPVSA-N

Alternative Forms

  1. Parent:

    ALA5182352

    ---

Associated Targets(Human)

TRPV1 Tclin Vanilloid receptor (8273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trpm8 Transient receptor potential cation channel subfamily M member 8 (889 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 373.50Molecular Weight (Monoisotopic): 373.2042AlogP: 4.78#Rotatable Bonds: 8
Polar Surface Area: 29.54Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.83CX LogP: 6.00CX LogD: 5.90
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.53Np Likeness Score: -0.40

References

1. Di Sarno V, Giovannelli P, Medina-Peris A, Ciaglia T, Di Donato M, Musella S, Lauro G, Vestuto V, Smaldone G, Di Matteo F, Bifulco G, Castoria G, Migliaccio A, Fernandez-Carvajal A, Campiglia P, Gomez-Monterrey I, Ostacolo C, Bertamino A..  (2022)  New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models.,  238  [PMID:35598411] [10.1016/j.ejmech.2022.114435]

Source